Skip to main content Skip to office menu Skip to footer
Capital IconMinnesota Legislature

HF 1029

as introduced - 86th Legislature (2009 - 2010) Posted on 02/09/2010 01:43am

KEY: stricken = removed, old language.
underscored = added, new language.

Bill Text Versions

Engrossments
Introduction Posted on 02/23/2009

Current Version - as introduced

Line numbers 1.1 1.2 1.3 1.4
1.5 1.6 1.7 1.8 1.9 1.10 1.11 1.12 1.13 1.14 1.15 1.16 1.17 1.18 1.19 1.20 1.21 1.22 1.23 1.24 2.1 2.2 2.3

A bill for an act
relating to economic development; appropriating money for BioBusiness
Alliance; requiring a report.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:

Section 1. new text begin BIOBUSINESS ALLIANCE APPROPRIATION.
new text end

new text begin (a) $1,100,000 is appropriated each year in fiscal years 2010 and 2011 from the
general fund to the commissioner of employment and economic development for the
operation of the BioBusiness Alliance of Minnesota. Funds must be used to:
new text end

new text begin (1) create, recruit, retain, and expand biobusiness activity in Minnesota;
new text end

new text begin (2) implement the destination 2025 statewide plan to promote the growth of
biobusiness in Minnesota including medical devices, biologics, biopharmaceuticals,
animal health, food, renewable energy, and renewable materials business activity in
Minnesota;
new text end

new text begin (3) update a statewide assessment of the bioscience industry and the competitive
position of Minnesota-based bioscience businesses relative to other states and other
nations; and
new text end

new text begin (4) develop and implement business and scenario-planning models to create, recruit,
retain, and expand biobusiness activity in Minnesota.
new text end

new text begin (b) The BioBusiness Alliance must report each year by February 15 to the
committees of the house of representatives and the senate having jurisdiction over
bioscience industry activity in Minnesota on:
new text end

new text begin (1) the use of funds;
new text end

new text begin (2) the number of bioscience businesses and jobs created, recruited, retained, or
expanded in the state since the last reporting period;
new text end

new text begin (3) the competitive position of the biobusiness industry; and
new text end

new text begin (4) utilization rates and results of the business and scenario-planning models and
outcomes resulting from utilization of the business and scenario-planning models.
new text end